[1]
Liu J., Wang S., Tian S., He Y., Lou H., Yang Z., Kong Y. and Cao X. 2018. Nobiletin inhibits breast cancer via p38 mitogen-activated protein kinase, nuclear transcription factor-κB, and nuclear factor erythroid 2-related factor 2 pathways in MCF-7 cells. Food & Nutrition Research. 62, (Nov. 2018). DOI:https://doi.org/10.29219/fnr.v62.1323.